Correlation Between Quest PharmaTech and Pieris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Quest PharmaTech and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quest PharmaTech and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quest PharmaTech and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Quest PharmaTech and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quest PharmaTech with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quest PharmaTech and Pieris Pharmaceuticals.
Diversification Opportunities for Quest PharmaTech and Pieris Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Quest and Pieris is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Quest PharmaTech and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Quest PharmaTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quest PharmaTech are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Quest PharmaTech i.e., Quest PharmaTech and Pieris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Quest PharmaTech and Pieris Pharmaceuticals
Assuming the 90 days horizon Quest PharmaTech is expected to under-perform the Pieris Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Quest PharmaTech is 2.05 times less risky than Pieris Pharmaceuticals. The pink sheet trades about -0.07 of its potential returns per unit of risk. The Pieris Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 7,040 in Pieris Pharmaceuticals on September 14, 2024 and sell it today you would lose (5,669) from holding Pieris Pharmaceuticals or give up 80.53% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Quest PharmaTech vs. Pieris Pharmaceuticals
Performance |
| Timeline |
| Quest PharmaTech |
| Pieris Pharmaceuticals |
Quest PharmaTech and Pieris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quest PharmaTech and Pieris Pharmaceuticals
The main advantage of trading using opposite Quest PharmaTech and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quest PharmaTech position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.| Quest PharmaTech vs. Coya Therapeutics, Common | Quest PharmaTech vs. Cue Biopharma | Quest PharmaTech vs. Lantern Pharma | Quest PharmaTech vs. Fennec Pharmaceuticals |
| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |